ID21979A - METHOD OF USING INHIBITORS-CYHOXOXIGAGE-2-INHIBITORS AS ANTI-ANGIOGENIC SUBSTANCE - Google Patents

METHOD OF USING INHIBITORS-CYHOXOXIGAGE-2-INHIBITORS AS ANTI-ANGIOGENIC SUBSTANCE

Info

Publication number: ID21979A
Authority: ID; Indonesia
Prior art keywords: inhibitors; cyhoxoxigage; angiogenic substance; angiogenic; substance
Prior art date: 1996-11-19

Application number

IDW990379A

Other languages

Indonesian (id)

Inventor

Jamie L Masferrer

Amiram Raz

Original Assignee

Searle & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-19

Filing date

1997-11-19

Publication date

1999-08-19

1997-11-19 Application filed by Searle & Co filed Critical Searle & Co

1999-08-19 Publication of ID21979A publication Critical patent/ID21979A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Ophthalmology & Optometry (AREA)
Reproductive Health (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyridine Compounds (AREA)

IDW990379A 1996-11-19 1997-11-19 METHOD OF USING INHIBITORS-CYHOXOXIGAGE-2-INHIBITORS AS ANTI-ANGIOGENIC SUBSTANCE ID21979A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US3140496P	1996-11-19	1996-11-19

Publications (1)

Publication Number	Publication Date
ID21979A true ID21979A (en)	1999-08-19

Family

ID=21859277

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW990379A ID21979A (en)	1996-11-19	1997-11-19	METHOD OF USING INHIBITORS-CYHOXOXIGAGE-2-INHIBITORS AS ANTI-ANGIOGENIC SUBSTANCE

Country Status (19)

Country	Link
EP (1)	EP0941080A2 (en)
JP (1)	JP2001505564A (en)
KR (1)	KR20000053362A (en)
CN (1)	CN1247470A (en)
AU (1)	AU730211B2 (en)
BR (1)	BR9713522A (en)
CA (1)	CA2270469C (en)
CZ (1)	CZ176899A3 (en)
ID (1)	ID21979A (en)
IL (1)	IL129604A (en)
NO (1)	NO992309L (en)
NZ (1)	NZ335853A (en)
PL (2)	PL194717B1 (en)
RO (1)	RO118566B1 (en)
RU (1)	RU2268716C2 (en)
SK (1)	SK59999A3 (en)
TR (1)	TR199901703T2 (en)
UA (1)	UA70294C2 (en)
WO (1)	WO1998022101A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6512121B2 (en)	1998-09-14	2003-01-28	G.D. Searle & Co.	Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6515014B2 (en)	1995-06-02	2003-02-04	G. D. Searle & Co.	Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6887893B1 (en)	1997-12-24	2005-05-03	Sankyo Company, Limited	Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
US6833373B1 (en)	1998-12-23	2004-12-21	G.D. Searle & Co.	Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US20030013739A1 (en) *	1998-12-23	2003-01-16	Pharmacia Corporation	Methods of using a combination of cyclooxygenase-2 selective inhibitors and thalidomide for the treatment of neoplasia
AU2209800A (en) *	1998-12-23	2000-07-31	G.D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia
EP1637137A3 (en) *	1999-03-10	2006-07-05	G.D. Searle LLC	Method and composition for administering a cyclooxygenase-2 inhibitor to animals
ATE294574T1 (en) *	1999-07-29	2005-05-15	Tularik Inc	COMBINATION THERAPY WITH PENTAFLUOROBENZENESULFONAMIDE AND PLATINUM DERIVATIVES
ES2243504T3 (en) *	2000-05-19	2005-12-01	Applied Research Systems Ars Holding N.V.	USE OF PIRAZOL DERIVATIVES TO TREAT INFERTILITY.
AU2002234165A1 (en)	2000-11-03	2002-05-27	Tularik, Inc.	Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
KR100686537B1 (en) *	2001-12-28	2007-02-27	씨제이 주식회사	Diaryl 1,2,4-triazole derivatives having excellent selectivity as inhibitors of cyclooxygenase-2
BR0312744A (en) *	2002-07-17	2005-04-26	Warner Lambert Co	Combination of an allosteric carboxylic matrix metalloproteinase-13 inhibitor with a selective cyclooxygenase-2 inhibitor other than celecoxib or valdecoxib
KR100484525B1 (en) *	2002-10-15	2005-04-20	씨제이 주식회사	Isothiazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
AT504159A1 (en) *	2006-08-16	2008-03-15	Marlyn Nutraceuticals Inc	USE OF PROTEASES
RU2475257C1 (en) *	2011-06-22	2013-02-20	Людмила Николаевна Третьяк	Preparation for increasing organism adaptability to extreme conditions
GB2496135B (en) *	2011-11-01	2015-03-18	Valirx Plc	Inhibitors of the interaction between a Src family kinase and an androgen receptor or estradiol receptor for treatment of endometriosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2297592A1 (en) *	1993-01-15	1994-07-21	G.D. Searle & Co.	Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5436265A (en) *	1993-11-12	1995-07-25	Merck Frosst Canada, Inc.	1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
PT731795E (en) *	1993-11-30	2000-05-31	Searle & Co	PYRAZOLYLBENZENESULFONAMIDES FOR THE TREATMENT OF INFLAMMATIONS
US5521213A (en) *	1994-08-29	1996-05-28	Merck Frosst Canada, Inc.	Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
ES2191069T3 (en) *	1994-12-21	2003-09-01	Merck Frosst Canada Inc	DIARIL-2- (5H) -FURANONAS AS COX-2 INHIBITORS.
US5691374A (en) *	1995-05-18	1997-11-25	Merck Frosst Canada Inc.	Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors

1997
- 1997-11-19 CZ CZ991768A patent/CZ176899A3/en unknown
- 1997-11-19 ID IDW990379A patent/ID21979A/en unknown
- 1997-11-19 EP EP97949579A patent/EP0941080A2/en not_active Withdrawn
- 1997-11-19 RU RU99112952/14A patent/RU2268716C2/en not_active IP Right Cessation
- 1997-11-19 SK SK599-99A patent/SK59999A3/en unknown
- 1997-11-19 JP JP52396098A patent/JP2001505564A/en not_active Withdrawn
- 1997-11-19 WO PCT/US1997/021489 patent/WO1998022101A2/en not_active Application Discontinuation
- 1997-11-19 PL PL97373973A patent/PL194717B1/en unknown
- 1997-11-19 NZ NZ335853A patent/NZ335853A/en not_active Application Discontinuation
- 1997-11-19 AU AU72982/98A patent/AU730211B2/en not_active Ceased
- 1997-11-19 IL IL12960497A patent/IL129604A/en not_active IP Right Cessation
- 1997-11-19 TR TR1999/01703T patent/TR199901703T2/en unknown
- 1997-11-19 RO RO99-00572A patent/RO118566B1/en unknown
- 1997-11-19 CN CN97181368A patent/CN1247470A/en active Pending
- 1997-11-19 CA CA002270469A patent/CA2270469C/en not_active Expired - Fee Related
- 1997-11-19 UA UA99063447A patent/UA70294C2/en unknown
- 1997-11-19 KR KR1019990704392A patent/KR20000053362A/en not_active Application Discontinuation
- 1997-11-19 BR BR9713522A patent/BR9713522A/en not_active Application Discontinuation
1999
- 1999-04-30 PL PL333370A patent/PL191793B1/en unknown
- 1999-05-12 NO NO992309A patent/NO992309L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO1998022101A2 (en)	1998-05-28
CA2270469A1 (en)	1998-05-28
JP2001505564A (en)	2001-04-24
NO992309D0 (en)	1999-05-12
CZ176899A3 (en)	1999-10-13
EP0941080A2 (en)	1999-09-15
PL333370A1 (en)	1999-12-06
CN1247470A (en)	2000-03-15
IL129604A (en)	2004-08-31
NO992309L (en)	1999-05-12
IL129604A0 (en)	2000-02-29
AU7298298A (en)	1998-06-10
KR20000053362A (en)	2000-08-25
PL191793B1 (en)	2006-07-31
UA70294C2 (en)	2004-10-15
BR9713522A (en)	2000-03-21
PL194717B1 (en)	2007-06-29
RU2268716C2 (en)	2006-01-27
WO1998022101A3 (en)	1998-06-25
CA2270469C (en)	2007-04-10
NZ335853A (en)	2002-02-01
AU730211B2 (en)	2001-03-01
TR199901703T2 (en)	2000-07-21
RO118566B1 (en)	2003-07-30
SK59999A3 (en)	2000-01-18

Publication	Publication Date	Title
ID17411A (en)	1997-12-24	METHOD OF PREPARATION-OBJECTS OF ABSORPTION OBJECTS
DK1121192T3 (en)	2006-11-27	Method of homogenization
IS8368A (en)	2006-03-22	New method
DK1085981T3 (en)	2003-11-17	Method of packaging
FI965268A (en)	1998-07-01	Method for the preparation of polyhydric alcohols
DK0806474T3 (en)	2003-03-03	Method of stabilizing beverages
ID21979A (en)	1999-08-19	METHOD OF USING INHIBITORS-CYHOXOXIGAGE-2-INHIBITORS AS ANTI-ANGIOGENIC SUBSTANCE
ID26990A (en)	2001-02-22	METHOD OF MAKING DIMETHYLNAFTALENA
DE69733883D1 (en)	2005-09-08	METHOD FOR THE ADDITION OF BORON COMPOUNDS
EE04154B1 (en)	2003-10-15	Method of preparation of omeprazole
DE69733962D1 (en)	2005-09-15	PLASMA-etching method
ID22098A (en)	1999-09-02	METHOD TO REMOVE CORETANS
ID20733A (en)	1999-02-25	METHOD OF MAKING BRUSH
DE69709695D1 (en)	2002-02-21	PAGE COMPOSITION METHOD
DK0987356T3 (en)	2009-11-30	Method of drawing
DK0874822T3 (en)	2003-12-08	New method of manufacture
DE69737237D1 (en)	2007-02-22	METHOD OF DRYING
ID18300A (en)	1998-03-26	METHOD OF PENEMPERAN
ID16838A (en)	1997-11-13	COMPOSITION OF DEKAFLUOROPENTANA
ID17941A (en)	1998-02-12	METHOD OF THE APPLICATION OF MARKA JALAN MAKERS COMPOSITION
ID17419A (en)	1997-12-24	COMPOSITION OF DEKAFLUOROPENTANA
ID23019A (en)	1999-12-30	METHOD OF MAKING NITROGUADININ DOWN
ATE218559T1 (en)	2002-06-15	METHOD FOR THE MONOACYLATION OF HYDROXYTAXANES
EE9900404A (en)	2000-04-17	Method for the preparation of arylaminotriazolopyridines
ID17503A (en)	1998-01-08	CONSTRUCTION METHOD